Advanced search
Start date
Betweenand

Development of a recombinant multicomponent chimeric vaccine based on protein epitopes from Rhipicephalus microplus ticks

Grant number: 15/19281-5
Support type:Scholarships in Brazil - Post-Doctorate
Effective date (Start): February 01, 2016
Effective date (End): January 31, 2017
Field of knowledge:Biological Sciences - Parasitology
Principal researcher:Beatriz Rossetti Ferreira
Grantee:Abid Ali
Home Institution: Escola de Enfermagem de Ribeirão Preto (EERP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
Associated research grant:15/09683-9 - Development of a recombinant multicomponent chimeric vaccine based in protein epitopes from Rhipicephalus microplus ticks, AP.TEM

Abstract

Ticks are important vectors of diseases to humans and animals and promote significant losses in the cattle production sector, while also induce expressive inconvenience to dogs owners. The control of tick infestations has been done with acaricides, but the selection of resistant parasites and environmental contamination point towards the need for alternative methods of control. Currently available vaccines against ticks depict variable outcomes of protection against ticks within cattle herds and short lasting immunological memory, stimulating the research for more efficient vaccines. In this project we propose to carry out the construction of a recombinant protein consisting of epitopes derived from proteins of R. microplus selected by SPOT peptide synthesis technique. Initially, fifteen selected recombinant proteins will be produced and evaluated with regards to their potential to protect mice against challenge by R. sanguineus ticks. The proteins that impair biological and reproductive parameters of ticks will be used to inoculate dogs and bovines to produce immune sera that will be used for epitope mapping by SPOT technique. Thereby, specific regions of the proteins which induce immunity in both animal species will be identified and incorporated in the chimeric vaccine. Finally, the sequences of the reagent epitopes will be used for the synthesis of a recombinant chimeric protein, allowing expression of the fused epitopes in a single structure. The recombinant multicomponent chimeric protein will be used to immunize mice that subsequently will undergo a challenge infestation with R. sanguineus ticks, which will be evaluated in order to determine its efficiency as a vaccine and the humoral and cellular response. If the chimeric protein shows to be efficient in mice, an preliminary clinical trial will be performed on dogs and bovines. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
PARIZI, L. F.; ALI, A.; TIRLONI, L.; OLDIGES, D. P.; SABADIN, G. A.; COUTINHO, M. L.; SEIXAS, A.; LOGULLO, C.; TERMIGNONI, C.; DA SILVA VAZ, JR., I.. Peptidase inhibitors in tick physiology. Medical and Veterinary Entomology, v. 32, n. 2, p. 129-144, . (15/19281-5)

Please report errors in scientific publications list by writing to: cdi@fapesp.br.